- /
- Supported exchanges
- / US
- / MKGAF.PINK
MERCK Kommanditgesellschaft auf Aktien (MKGAF PINK) stock market data APIs
MERCK Kommanditgesellschaft auf Aktien Financial Data Overview
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a sub
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get MERCK Kommanditgesellschaft auf Aktien data using free add-ons & libraries
Get MERCK Kommanditgesellschaft auf Aktien Fundamental Data
MERCK Kommanditgesellschaft auf Aktien Fundamental data includes:
- Net Revenue: 21 135 M
- EBITDA: 5 587 M
- Earnings Per Share: 6
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get MERCK Kommanditgesellschaft auf Aktien Earnings data
Corporate Events Calendar & News package for
What’s included:
- Latest Release: 2026-08-06
- EPS/Forecast: 2.04
Get MERCK Kommanditgesellschaft auf Aktien End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MERCK Kommanditgesellschaft auf Aktien News
New
Capitalize on Surging Drug and Diagnostics Demand: Benchmark Merck KGaA, Cambridge Isotope Laboratories, IsoSciences and Toronto Research Chemicals to Secure Stable Isotope Revenue Leadership
Company Logo Demand is rising with pharmaceutical R&D, stricter drug-testing rules, advanced analytics and environmental monitoring, while trade shifts may reshape sourcing. Dublin, Sept. 22, 2026 (...
Capitalize on the PEGylated Proteins Revenue Shift: Benchmark Amgen, Roche, Merck KGaA, Pfizer and Novo Nordisk to Secure Competitive ROI Through the Forecast Period
Company Logo Site-specific PEGylation is enabling safer, longer-acting biologics, while demand in chronic disease, targeted therapies and biosimilars creates opportunities for services and reagents. ...
Capitalize on the Aseptic Sampling Shift: Benchmark Merck KGaA, Sartorius, Thermo Fisher Scientific, Danaher and GEA to Secure Bioprocessing ROI Across the Forecast Period
Company Logo Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance. Dubl...
Oligonucleotide Synthesis Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Merck KGaA, and Integrated DNA Technologies
Company Logo Oligonucleotide Synthesis Gains Momentum as Precision Medicine, Gene Editing and Therapeutic Pipelines Drive GMP Capacity Expansion and Partnerships Dublin, Sept. 15, 2026 (GLOBE NEWSWI...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.